QUESTCOR PHARMACEUTICALS INC's ticker is QCOR and the CUSIP is 74835Y101. A total of 251 filers reported holding QUESTCOR PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.71 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2014 | $99,594,000 | +2529.2% | 1,076,813 | +1745.7% | 0.27% | +2336.4% |
Q1 2014 | $3,788,000 | +17.4% | 58,343 | -1.5% | 0.01% | +10.0% |
Q4 2013 | $3,226,000 | -13.5% | 59,243 | -7.9% | 0.01% | -23.1% |
Q3 2013 | $3,731,000 | +63.1% | 64,327 | +27.8% | 0.01% | +62.5% |
Q2 2013 | $2,288,000 | +1.6% | 50,326 | -40.3% | 0.01% | -20.0% |
Q4 2012 | $2,253,000 | – | 84,301 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 3,296,660 | $149,800,000 | 34.05% |
Valiant Capital Management, L.P. | 913,693 | $41,518,000 | 4.98% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 366,625 | $16,659,000 | 4.35% |
Freshford Capital Management, LLC | 575,000 | $26,128,000 | 3.87% |
Palo Alto Investors LP | 696,297 | $31,640,000 | 3.73% |
RIVULET CAPITAL, LLC | 100,000 | $4,544,000 | 3.62% |
CAPITAL MANAGEMENT CORP /VA | 190,135 | $8,640,000 | 3.59% |
Consonance Capital Management LP | 200,000 | $9,088,000 | 3.23% |
DIALECTIC CAPITAL MANAGEMENT, LP | 407,400 | $18,513,000 | 2.70% |
Freestone Capital Holdings, LLC | 268,738 | $12,211,000 | 2.50% |